Streetbeat News

Earnings

ACB

Aurora Cannabis Inc. (NASDAQ:ACB) will report its Q1 2025 earnings on August 7, 2024. The company recently received two licenses in Germany for domestic cultivation under the new Medical Cannabis Act. Analyst Pablo Zuanic emphasized the need for Aurora to prove its growth strategies in a competitive market. Aurora aims for a 10% market share in the international medical marijuana market, potentially increasing its sales to CA$700 million.

Portfolio Pulse from Jelena Martinovic

July 29, 2024 | 4:04 pm

CGTX

LIPO

NLSP

VERO

VTVT

VTYX

U.S. stocks traded mostly higher on Monday, with the Nasdaq Composite gaining 0.4%. ON Semiconductor reported better-than-expected Q2 results. Shares of NLS Pharmaceutics surged 54% following a merger announcement. Lipella Pharmaceuticals and Venus Concept also saw significant gains. Meanwhile, vTv Therapeutics, Cognition Therapeutics, and Ventyx Biosciences experienced notable declines.

Portfolio Pulse from Avi Kapoor

July 29, 2024 | 4:03 pm

AMD

INTC

VGT

VTV

Rosenblatt analyst Hans Mosesmann maintained a Sell rating on Intel Corp (NASDAQ:INTC) with a price target of $17, citing competition from AMD as a key challenge. Mosesmann expects Intel to deliver inline Q2 earnings with modest growth guidance for Q3. He projects lower-than-consensus revenue and EPS for fiscal 2024 and 2025. Intel stock has lost over 13% in the last 12 months. Investors can gain exposure through Vanguard Value ETF (NYSE:VTV) and Vanguard Information Tech ETF (NYSE:VGT).

Portfolio Pulse from Anusuya Lahiri

July 29, 2024 | 4:02 pm

IBTX

Five analysts have evaluated Independent Bank Group (NASDAQ: IBTX) over the past three months, showing a mix of bullish and bearish perspectives. The average 12-month price target has increased to $55.8, reflecting a 17.72% rise from the previous target. Analysts have adjusted their ratings and price targets, with some raising their targets significantly. Despite positive revenue growth, the company faces challenges with net margin, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

July 29, 2024 | 4:01 pm

BMY

Bristol-Myers Squibb (NYSE:BMY) reported strong Q2 earnings, leading to mixed analyst reactions. Barclays downgraded the stock to Underweight, citing concerns over long-term fundamentals, while Goldman Sachs reiterated a Buy rating, highlighting operational achievements and growth potential of new products.

Portfolio Pulse from Priya Nigam

July 29, 2024 | 3:59 pm

AAPL

Apple Inc. (NASDAQ:AAPL) has delayed the launch of its new AI features, Apple Intelligence, from September to October. The company aims to ensure stability and performance for these generative AI capabilities. Despite recent stock fluctuations, Apple has seen a 13% increase year-to-date. The Q3 earnings report on August 1 could significantly impact the stock price.

Portfolio Pulse from Zaheer Anwari

July 29, 2024 | 3:54 pm

AMZN

Amazon.com, Inc. (NASDAQ:AMZN) is trending as it prepares to report its 2024 fiscal year second quarter earnings on Thursday. Analysts estimate an EPS of $1.03 and revenue of $148.56 billion. Recent analyst coverage includes price target adjustments from BMO Capital and Wedbush.

Portfolio Pulse from Dylan Berman

July 29, 2024 | 3:38 pm

CGTX

Cognition Therapeutics (NASDAQ:CGTX) reported mixed results from its Phase 2 'SHINE' study for Alzheimer's treatment CT1812. While there were trends of cognitive improvement and functional benefits, the drug did not achieve statistical significance on secondary efficacy endpoints. The stock fell 35.10% to $1.54 following the news.

Portfolio Pulse from Vandana Singh

July 29, 2024 | 3:31 pm

AMC

DIS

AMC Entertainment Holdings Inc (NYSE:AMC) shares are rising after the company reported record-breaking weekend attendance and admissions revenue for 2024. The success was driven by the opening weekend of Walt Disney Co (NYSE:DIS) and Marvel's 'Deadpool & Wolverine,' which set new records for an R-rated film. AMC also saw its highest food and beverage revenue since 2019 and strong merchandise sales.

Portfolio Pulse from Adam Eckert

July 29, 2024 | 3:24 pm

CTRI

Centuri shares are trading lower after the company reported worse-than-expected Q2 earnings and provided lower-than-expected 2024 guidance.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 3:16 pm